Institutional Ownership Royalty Pharma PLC (RPRX)
This table provides information about the institutional ownership of Royalty Pharma PLC (RPRX). We have compiled data on the 536 institutions that hold shares in the stock, with a total of 304 Million shares, which have been reported (via 13F filing form) to have a value of $11.9 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
44,163,954
shares
|
$1.73 Billion
0.1% of portfolio
|
Q3 2025
Reduced 5.24%
|
|
|
Capital International Investors
Los Angeles, CA |
Nov 13, 2025 Q3 2025 |
27,212,694
shares
|
$1.07 Billion
0.16% of portfolio
|
Q3 2025
Added 24.37%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
23,017,561
shares
|
$901 Million
0.01% of portfolio
|
Q2 2024
Added 8.54%
|
|
|
Baillie Gifford & CO
|
Oct 31, 2025 Q3 2025 |
17,372,502
shares
|
$680 Million
0.48% of portfolio
|
Q3 2025
Reduced 3.6%
|
|
|
Swedbank Ab
Stockholm, V7 |
Oct 15, 2025 Q3 2025 |
12,200,270
shares
|
$478 Million
0.45% of portfolio
|
Q3 2025
Added 0.35%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2025 Q3 2025 |
11,965,633
shares
|
$469 Million
0.71% of portfolio
|
Q3 2025
Added 99.43%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 07, 2025 Q3 2025 |
10,936,538
shares
|
$428 Million
0.01% of portfolio
|
Q3 2025
Reduced 69.94%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
10,272,753
shares
|
$402 Million
0.01% of portfolio
|
Q3 2025
Added 0.76%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2025 Q3 2025 |
7,617,413
shares
|
$298 Million
0.02% of portfolio
|
Q3 2025
Reduced 6.84%
|
|
|
Caledonia (Private) Investments Pty LTD
Sydney Nsw, C3 |
Nov 14, 2025 Q3 2025 |
7,547,609
shares
|
$296 Million
6.31% of portfolio
|
Q3 2025
Added 17.11%
|
|
|
Victory Capital Management Inc
|
Nov 12, 2025 Q3 2025 |
4,657,407
shares
|
$182 Million
0.11% of portfolio
|
Q3 2025
Added 3.69%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
4,075,239
shares
|
$160 Million
0.02% of portfolio
|
Q3 2025
Added 1.33%
|
|
|
Siguler Guff Advisers, LLC
|
Feb 15, 2023 Q4 2022 |
3,391,754
shares
|
$133 Million
64.43% of portfolio
|
Q4 2022
Reduced 49.84%
|
|
|
Arrowstreet Capital, Limited Partnership
Boston, MA |
Nov 13, 2025 Q3 2025 |
3,282,174
shares
|
$129 Million
0.08% of portfolio
|
Q3 2025
Added 10.27%
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
3,151,660
shares
|
$123 Million
0.02% of portfolio
|
Q3 2025
Added 314.63%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2025 Q3 2025 |
3,129,936
shares
|
$123 Million
0.02% of portfolio
|
Q3 2025
Reduced 23.23%
|
|
|
Patient Capital Management, LLC
Baltimore, MD |
Oct 29, 2025 Q3 2025 |
3,117,850
shares
|
$122 Million
5.07% of portfolio
|
Q3 2025
Added 4.35%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 10, 2025 Q3 2025 |
3,025,712
shares
|
$118 Million
0.02% of portfolio
|
Q3 2025
Added 0.56%
|
|
|
New South Capital Management Inc
Memphis, TN |
Nov 06, 2025 Q3 2025 |
2,918,263
shares
|
$114 Million
5.28% of portfolio
|
Q3 2025
Added 1.1%
|
|
|
Legal & General Group PLC
London, X0 |
Nov 13, 2025 Q3 2025 |
2,822,566
shares
|
$111 Million
0.02% of portfolio
|
Q3 2025
Added 3.81%
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2025 Q3 2025 |
2,646,772
shares
|
$104 Million
0.01% of portfolio
|
Q3 2025
Added 29.66%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
2,481,771
shares
|
$97.2 Million
0.1% of portfolio
|
Q3 2025
Added 737.29%
|
|
|
Pat Dorsey
Dorsey Asset Management, LLC | Chicago, Il
|
Nov 14, 2025 Q3 2025 |
2,350,449
shares
|
$92 Million
7.45% of portfolio
|
Q3 2025
New holding
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2025 Q3 2025 |
2,235,133
shares
|
$87.5 Million
0.04% of portfolio
|
Q3 2025
Added 379.2%
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
2,100,490
shares
|
$82.3 Million
0.02% of portfolio
|
Q3 2025
Added 10.84%
|
|